Michael S. Leapman

590 total citations
21 papers, 403 citations indexed

About

Michael S. Leapman is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Michael S. Leapman has authored 21 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 8 papers in Surgery and 4 papers in Oncology. Recurrent topics in Michael S. Leapman's work include Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (14 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Michael S. Leapman is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (14 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Michael S. Leapman collaborates with scholars based in United States, Australia and United Kingdom. Michael S. Leapman's co-authors include Peter R. Carroll, Janet E. Cowan, Katsuto Shinohara, Hao G. Nguyen, Sophie Bruinsma, Antti Rannikko, Neophytos Petrides, Monique J. Roobol, Mahesha Weerakoon and Leonard P. Bokhorst and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and The Journal of Urology.

In The Last Decade

Michael S. Leapman

19 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael S. Leapman United States 10 350 100 83 73 56 21 403
Richard Savdie Australia 11 313 0.9× 103 1.0× 51 0.6× 98 1.3× 106 1.9× 20 413
Romain Diamand Belgium 13 358 1.0× 83 0.8× 67 0.8× 91 1.2× 127 2.3× 49 445
Alex Gorbonos United States 10 298 0.9× 60 0.6× 38 0.5× 106 1.5× 40 0.7× 32 358
Jonathan Brajtbord United States 12 387 1.1× 101 1.0× 39 0.5× 133 1.8× 65 1.2× 22 464
Rafael Tourinho‐Barbosa France 12 429 1.2× 96 1.0× 32 0.4× 154 2.1× 65 1.2× 28 494
Wesley W. Choi United States 8 299 0.9× 91 0.9× 71 0.9× 63 0.9× 59 1.1× 11 435
Petra Strölin Germany 4 436 1.2× 150 1.5× 88 1.1× 72 1.0× 46 0.8× 5 468
Antony Pellegrino Italy 9 268 0.8× 163 1.6× 62 0.7× 72 1.0× 43 0.8× 34 371
Gunna Aus Sweden 4 569 1.6× 113 1.1× 105 1.3× 153 2.1× 84 1.5× 8 653
E. Martinez Spain 9 242 0.7× 83 0.8× 72 0.9× 45 0.6× 26 0.5× 20 332

Countries citing papers authored by Michael S. Leapman

Since Specialization
Citations

This map shows the geographic impact of Michael S. Leapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Leapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Leapman more than expected).

Fields of papers citing papers by Michael S. Leapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Leapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Leapman. The network helps show where Michael S. Leapman may publish in the future.

Co-authorship network of co-authors of Michael S. Leapman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Leapman. A scholar is included among the top collaborators of Michael S. Leapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Leapman. Michael S. Leapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cavallo, Jaime A., et al.. (2025). Comprehensive Outcome Analysis of Single-Port Robot-Assisted Radical Prostatectomy. Journal of Endourology. 40(3). 321–327.
2.
Lokeshwar, Soum D., Victor Kong, Vinaik Sundaresan, et al.. (2024). Pathologic prostate cancer grade concordance among high-resolution micro-ultrasound, systematic transrectal ultrasound and MRI fusion biopsy. Urologic Oncology Seminars and Original Investigations. 43(5). 336.e13–336.e20.
3.
Sundaresan, Vinaik, James A. Bailey, Paweł Rajwa, et al.. (2024). Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI. Urologic Oncology Seminars and Original Investigations. 43(3). 193.e19–193.e26. 1 indexed citations
4.
Leapman, Michael S., Yang Liu, Christopher P. Filson, et al.. (2024). Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world Setting. European Urology Oncology. 8(4). 1101–1110. 2 indexed citations
5.
Loeb, Stacy, et al.. (2024). Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer, 2010-2020. JAMA. 332(23). 2033–2033. 4 indexed citations
6.
Leapman, Michael S., Janet E. Cowan, Hao G. Nguyen, et al.. (2017). Active Surveillance in Younger Men With Prostate Cancer. Journal of Clinical Oncology. 35(17). 1898–1904. 36 indexed citations
7.
Leapman, Michael S., Zhen J. Wang, Spencer C. Behr, et al.. (2017). Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer. Radiologia Brasileira. 50(5). 299–307. 10 indexed citations
8.
Tran, Geraldine, Michael S. Leapman, Hao G. Nguyen, et al.. (2016). Magnetic Resonance Imaging–Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance. European Urology. 72(2). 275–281. 73 indexed citations
9.
Leapman, Michael S., Nelson N. Stone, Stephen Mock, Richard G. Stock, & Simon J. Hall. (2016). Urinary Incontinence Following Prostate Brachytherapy. Urology. 95. 151–157. 9 indexed citations
10.
Bruinsma, Sophie, Chris H. Bangma, Peter R. Carroll, et al.. (2016). Active surveillance for prostate cancer: a narrative review of clinical guidelines. Nature Reviews Urology. 13(3). 151–167. 126 indexed citations
11.
Leapman, Michael S., Janet E. Cowan, Hao G. Nguyen, et al.. (2016). Relationship of phosphodiesterase type 5 inhibitor to biochemical recurrence after definitive therapy for prostate cancer.. Journal of Clinical Oncology. 34(2_suppl). 119–119. 4 indexed citations
12.
Izadmehr, Sudeh, et al.. (2016). Clinical characteristics and outcomes of HIV-seropositive men treated with surgery for prostate cancer. International Urology and Nephrology. 48(10). 1639–1645. 11 indexed citations
13.
Leapman, Michael S., Stephen J. Freedland, William J. Aronson, et al.. (2016). Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy. The Journal of Urology. 196(5). 1408–1414. 41 indexed citations
14.
Nguyen, Hao G., Sanoj Punnen, Janet E. Cowan, et al.. (2016). A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical Prostatectomy. The Journal of Urology. 197(2). 369–375. 16 indexed citations
15.
Leapman, Michael S., Stephen J. Freedland, Christopher J. Kane, et al.. (2016). Pathologic and biochemical outcomes among African American and Caucasian men with low-risk prostate cancer in the search database: Implications for active surveillance candidacy.. Journal of Clinical Oncology. 34(2_suppl). 76–76. 1 indexed citations
16.
Leapman, Michael S. & Peter R. Carroll. (2015). New Genetic Markers for Prostate Cancer. Urologic Clinics of North America. 43(1). 7–15. 8 indexed citations
17.
Carlsson, Sigrid, Michael S. Leapman, Peter R. Carroll, et al.. (2015). Who and when should we screen for prostate cancer? Interviews with key opinion leaders. BMC Medicine. 13(1). 288–288. 9 indexed citations
18.
Leapman, Michael S., Antonio C. Westphalen, Niloufar Ameli, et al.. (2015). Association between a 17-gene genomic prostate score and multiparametric prostate MRI in men with low- and intermediate-risk prostate cancer (PCa).. Journal of Clinical Oncology. 33(7_suppl). 83–83. 4 indexed citations
19.
Hussein, Ahmed A., Janet E. Cowan, Michael S. Leapman, et al.. (2015). Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes. The Journal of Urology. 194(1). 85–90. 10 indexed citations
20.
Jalloh, Mohamed, Michael S. Leapman, Janet E. Cowan, et al.. (2015). Patterns of Local Failure following Radiation Therapy for Prostate Cancer. The Journal of Urology. 194(4). 977–982. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Savdie Breakdown of academic impact, for papers by Romain Diamand Breakdown of academic impact, for papers by Alex Gorbonos Breakdown of academic impact, for papers by Jonathan Brajtbord Breakdown of academic impact, for papers by Rafael Tourinho‐Barbosa Breakdown of academic impact, for papers by Wesley W. Choi Breakdown of academic impact, for papers by Petra Strölin Breakdown of academic impact, for papers by Antony Pellegrino Breakdown of academic impact, for papers by Gunna Aus Breakdown of academic impact, for papers by E. Martinez
Rankless by CCL
2026